-+ 0.00%
-+ 0.00%
-+ 0.00%

UK Approves Eli Lilly's Weight-loss Pill Foundayo

MT Newswires·08/10/2026 08:02:10
Listen to the news
08:02 AM EDT, 08/10/2026 (MT Newswires) -- The UK's Medicines and Healthcare products Regulatory Agency approved Eli Lilly's (LLY.SW) Foundayo, or orforglipron, pill for weight management and type 2 diabetes, according to a Monday release. The decision makes the UK the first country in Europe to approve the GLP-1 tablet for weight management in adults with a body mass index of 30 or above, or between 27 and 30 with at least one weight-related comorbidity. The tablet is also authorized to improve glycemic control in adults with insufficiently controlled type 2 diabetes.